Granulocyte colony stimulating factor in myocardial infarction with low ejection fraction

Cytokine

Volumn 51, Issue 3, 2010, Pages 278-285

  Angeli, Franca S ^a   Smith, Charles ^a   Amabile, Nicolas ^a   Shapiro, Mia ^a   Bartlett, Lauren ^b   Virmani, Renu ^b   Chatterjee, Kanu ^a   Boyle, Andrew ^a   Grossman, William ^a   Yeghiazarians, Yerem ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CVPATH INSTITUTE   (United States)

Author keywords

Cardiac remodeling; Cytokine; Granulocyte colony stimulating factor; Myocardial infarction

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SODIUM CHLORIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HEART VENTRICLE WALL MOTION; HISTOPATHOLOGY; INFLAMMATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEUKOCYTE COUNT; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; SWINE; TRANSTHORACIC ECHOCARDIOGRAPHY; ANGIOGENESIS; ANIMAL; CATHETERIZATION; CELL MOTION; CYTOLOGY; DRUG EFFECTS; ECHOGRAPHY; FIBROSIS; HEART STROKE VOLUME; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCAR; TIME;

ANIMALIA; SUIDAE; SUS;

ANIMALS; BONE MARROW CELLS; CATHETERIZATION; CELL MOVEMENT; CICATRIX; FIBROSIS; GRANULOCYTE COLONY-STIMULATING FACTOR; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; STROKE VOLUME; SUS SCROFA; TIME FACTORS;

EID: 77955269820     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.06.003     Document Type: Article

References (33)

1. Hartwell D., Colquitt J., Loveman E., Clegg A.J., Brodin H., Waugh N., et al. Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation. Health Technol Assess 2005, 9:1-99. iii-iv.
2. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B., Flegal K., et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21-e181.
3. Kannel W.B., Feinleib M. Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol 1972, 29:154-163.
4. Dawn B., Guo Y., Rezazadeh A., Huang Y., Stein A.B., Hunt G., et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 2006, 98:1098-1105.
5. Harada M., Qin Y., Takano H., Minamino T., Zou Y., Toko H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005, 11:305-311.
6. Miki T., Miura T., Nishino Y., Yano T., Sakamoto J., Nakamura Y., et al. Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats. Clin Exp Pharmacol Physiol 2004, 31:873-882.
7. van der Meer P., Lipsic E., Henning R.H., de Boer R.A., Suurmeijer A.J., van Veldhuisen D.J., et al. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury. Eur J Heart Fail 2004, 6:853-859.
8. Anderlini P., Donato M., Chan K.W., Huh Y.O., Gee A.P., Lauppe M.J., et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 1999, 39:555-560.
9. Demetri G.D., Griffin J.D. Granulocyte colony-stimulating factor and its receptor. Blood 1991, 78:2791-2808.
10. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001, 98:10344-10349.
11. Minatoguchi S., Takemura G., Chen X.H., Wang N., Uno Y., Koda M., et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 2004, 109:2572-2580.
12. Iwanaga K., Takano H., Ohtsuka M., Hasegawa H., Zou Y., Qin Y., et al. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem Biophys Res Commun 2004, 325:1353-1359.
13. Kang H.J., Kim H.S., Zhang S.Y., Park K.W., Cho H.J., Koo B.K., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004, 363:751-756.
14. Ince H., Petzsch M., Kleine H.D., Eckard H., Rehders T., Burska D., et al. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation 2005, 112:I73-I80.
15. Ripa R.S., Jorgensen E., Wang Y., Thune J.J., Nilsson J.C., Sondergaard L., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 2006, 113:1983-1992.
16. Zohlnhofer D., Ott I., Mehilli J., Schomig K., Michalk F., Ibrahim T., et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 2006, 295:1003-1010.
17. Abdel-Latif A., Bolli R., Zuba-Surma E.K., Tleyjeh I.M., Hornung C.A., Dawn B. Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J 2008, 156:216-226. e9.
18. Ellis S.G., Penn M.S., Bolwell B., Garcia M., Chacko M., Wang T., et al. Granulocyte colony stimulating factor in patients with large acute myocardial infarction: results of a pilot dose-escalation randomized trial. Am Heart J 2006, 152:1051. e9- 14.
19. Engelmann M.G., Theiss H.D., Hennig-Theiss C., Huber A., Wintersperger B.J., Werle-Ruedinger A.E., et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 2006, 48:1712-1721.
20. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006, 27:2775-2783.
21. Angeli F.S., Shapiro M., Amabile N., Orcino G., Smith C.S., Tacy T., et al. Left ventricular remodeling after myocardial infarction: characterization of a swine model on beta-blocker therapy. Comp Med 2009, 59:272-279.
22. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2:358-367.
23. Baan J., Van der Velde E.T. Sensitivity of left ventricular end-systolic pressure-volume relation to type of loading intervention in dogs. Circ Res 1988, 62:1247-1258.
24. Glower D.D., Spratt J.A., Snow N.D., Kabas J.S., Davis J.W., Olsen C.O., et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 1985, 71:994-1009.
25. Amado L.C., Schuleri K.H., Saliaris A.P., Boyle A.J., Helm R., Oskouei B., et al. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol 2006, 48:2116-2124.
26. Cerqueira M.D., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002, 105:539-542.
27. Hasegawa H., Takano H., Iwanaga K., Ohtsuka M., Qin Y., Niitsuma Y., et al. Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia. J Am Coll Cardiol 2006, 47:842-849.
28. Beohar N., Flaherty J.D., Davidson C.J., Vidovich M., Singhal S., Rapp J.A., et al. Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing. Catheter Cardiovasc Interv 2007, 69:257-266.
29. Lee S.S., Naqvi T.Z., Forrester J., Cattley R., Shah A., Frantzen M., et al. The effect of granulocyte colony stimulating factor on regional and global myocardial function in the porcine infarct model. Int J Cardiol 2007, 116:225-230.
30. Valgimigli M., Rigolin G.M., Cittanti C., Malagutti P., Curello S., Percoco G., et al. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur Heart J 2005, 26:1838-1845.
31. Takano H., Hasegawa H., Kuwabara Y., Nakayama T., Matsuno K., Miyazaki Y., et al. Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction. Int J Cardiol 2007, 122:41-47.
32. Leone A.M., Galiuto L., Garramone B., Rutella S., Giannico M.B., Brugaletta S., et al. Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). Am J Cardiol 2007, 100:397-403.
33. Fuchs S., Baffour R., Zhou Y.F., Shou M., Pierre A., Tio F.O., et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001, 37:1726-1732.